Epidémiologie et traitement des prostatites aiguës après biopsie prostatique

Lobel, 1998, Biopsies transrectales de prostate et infection. Antibiotherapie ou antibioprophylaxie ?, Prog. Urol., 8, 578

Peyromaure, 2002, Pain and morbidity of an extensive prostate 10-biopsy protocol : A prospective study in 289 patients, J. Urol., 167, 218, 10.1016/S0022-5347(05)65416-X

Rodriguez Larissa, 1998, Risks and complications of transrectal ultrasound guided prostate needle biopsy : a prospective study and review of the literature, J. Urol., 160, 2115, 10.1016/S0022-5347(01)62255-9

Legrand P., Soussy C.J. : Ecologie bacterienne urinaire et resistance aux antibiotiques en urologie. Evenements AP-HP, Hôpital Henri Mondor, Janv. 2006, Diaporama.

Raaijmakers, 2002, Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program, Urol., 60, 826, 10.1016/S0090-4295(02)01958-1

Samson, 2007, Meningite à Escherichia Coli multiresistant apres biopsie de prostate transrectale, Ann. Fr. d’Anesthesie et de Reanimation, 26, 88, 10.1016/j.annfar.2006.08.011

Villers, 2004, Conditions de realisation et schema de ponctions lors d’une premiere serie de biopsies prostatiques, Prog. Urol., 14, 144

Tal, 2003, Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy, J. Urol., 169, 1762, 10.1097/01.ju.0000061280.23447.29

Cariou, 2003, Infections urinaires nosocomiales (IUN) : prevention en chirurgie (dont urologie), Medecine et Maladies Infectieuses, 33, 513, 10.1016/S0399-077X(03)00154-9

Crundwell, 1999, Patients tolerance for transrectal ultrasound-guided prostatic biopsy : an audit of 104 cases, BJU Int., 83, 792, 10.1046/j.1464-410x.1999.00011.x

Anon. Conférence de consensus 1992, Actualisation 1999 : Recommandations pour la pratique de l’antibioprophylaxie en chirurgie, 1999 ; 1-18.

Taylor, 1997, Antibiotic prophylaxis for transrectal prostate biopsy, J. Antimicrob. Chemother., 39, 115, 10.1093/jac/39.2.115

Ruebusch, 1979, A double blind study of trimethoprim-sulfamethoxazole prphylaxis in patients having transrectal needle biopsy of the prostate, J. Urol., 122, 492, 10.1016/S0022-5347(17)56477-0

Isen, 1999, Antibiotic prophylaxis for transrectal biopsy of the prostate : a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole, Int. Urol. Nephrol., 31, 491, 10.1023/A:1007115312039

Desmond, 1993, Morbidity with contemporary prostate biopsy, J. Urol., 150, 1425, 10.1016/S0022-5347(17)35798-1

Rietbergen, 1997, Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program, Urology, 49, 875, 10.1016/S0090-4295(97)00100-3

Brewster, 1995, Antimicrobial prophylaxis for transrectal prostatic biopsy : a prospective randomized trial of cefuroxime versus piperacillin/tazobactam, Br. J. Urol., 76, 351, 10.1111/j.1464-410X.1995.tb07713.x

Fluit, 2000, Antimicrobial resistance among urinary tract infection (UTI) isolâtes in Europe : results from the SENTRY Antimicrobial Surveillance Program 1997, Antoine Van Leeuwenhoek, 77, 147, 10.1023/A:1002003123629

Colodner, 2001, Antimicrobial susceptibility of community-aquired uropathogens in northern Israel, Int. J. Antimicrob. Agents, 18, 189, 10.1016/S0924-8579(01)00368-5

Daza, 2001, Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infection, Int. J. Antimicrob. Agents, 18, 189, 10.1016/S0924-8579(01)00389-2